chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pediatric dose was given to adults mistakenly; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (dose was given to adults mistakenly).    This case is for patient 39 of 104 patients.  No concomitant medications were reported.  It was reported that Batch no. 051B22A was kept in the freezer upon receipt of shipment on 08-Jan-2022 and individual vials were put in the refrigerator on the day of use. Batch no. AR5186C was previously reported. dose was given to adults mistakenly and each patient received the error dose, with instructions to re-vaccinate 2 months from the initial error dose.  No treatment medications were reported.
This spontaneous report as received from a other health professional refers to a female patient of unknown age. The patient medical history and historical conditions were not reported. On 15-MAY-2014, the patient was vaccinated with (Oka-Merck) PROQUAD (lot # J009885 and expiration date 12-FEB-2015) subcutaneous, in the left arm (deltoid). These were their out of range temp logs and vaccines that have been administered to different patients and no adverse event. The outcome of out of range temp logs and vaccines that have been administered to different patients and no adverse event was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
local DTP reaction @ site of DTP arm sl red, warm to touch, swollen & tender; 2 1/2" circumference systemic-fever 1 day p/DTP;
Pain at the time of injection that lasted for 6 hours; screaming, crying, inconsolable. Reddened raised area .5" diameter at injection site; resolved to 1/16" by 24 hours. Tender to touch.
like I had the flu for a day. My husband had the same reaction; This case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by the patient's spouse. The age at vaccination was not reported. After the second shot, the patient had flu for a day. The reporter stated that it was still better than getting shingles and strongly advise the shot. The reporter's daughter just had Shingles at age 30 and she was miserable. This case is one of the 4 cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR188154: US-GLAXOSMITHKLINE-US2021AMR188159: US-GLAXOSMITHKLINE-US2021AMR188157:
left hand was swollen; pain in left wrist joint; pain in his hand; can barely move it; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (left hand was swollen), ARTHRALGIA (pain in left wrist joint), PAIN IN EXTREMITY (pain in his hand) and MUSCULAR WEAKNESS (can barely move it) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PERIPHERAL SWELLING (left hand was swollen), ARTHRALGIA (pain in left wrist joint), PAIN IN EXTREMITY (pain in his hand) and MUSCULAR WEAKNESS (can barely move it). At the time of the report, PERIPHERAL SWELLING (left hand was swollen), ARTHRALGIA (pain in left wrist joint), PAIN IN EXTREMITY (pain in his hand) and MUSCULAR WEAKNESS (can barely move it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        Concomitant medications reported were blood pressure meds for drug use for unknown indication. Treatment details were not provided.
Shoulder pain, Adhesive capsulitis diagnosis, steroid injection and Phys. therapy. On May 6 I received an injection of PREVNAR 13 in my PCP office during my annual physical. The next day I woke with a sore Left shoulder and flu like symptoms, which I was told could be a side effect. The flu symptoms w/fever 101 lasted 1 day, then subsided. The sore left arm remained and became red and itchy and had a baseball size lump, but resolved in a few days. The injection area remained tender. In the next week 5-10-16, I reached up for a seatbelt and felt a quick sharp pain. When it did not resolve and my range of motion decreased, I saw doctor thinking it was a strain. I saw him 5 times over the next 2 wks with no improvement. He treated me with stim therapy, manipulation and exercise and diagnosed left lateral deltoid strain the pain worsened and R.O.M diminished on 6/29/2016. I saw ortho surgeon who diagnosed adhesive capsulitis and injected area w/steroid and prescribed P.T. I have completed to date 14 P.T. sessions and am regaining R.O.M. Pain levels fluctuate. Limited Daily Activities due to R.O.M and Pain.
After developing soreness at the injection site about 6-8 hours post injection, I developed chills and thirst, at 4:30am I got up to go to urinate and afterward I was feeling light headed. I sat on the edge of the tub. After a couple of minutes I went to get up and fainted on the floor.  My BP was 89/49 with a pulse of 86bpm. I was helped off the floor and back to bed where I lay with my feet elevated by a couple of pillows. No further issues at this time.
needle like pain across back and neck; needle like pain across back and neck; weakness in left arm; initial faintness at onset; This is a spontaneous report from a contactable consumer (patient). A 27-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EW0170), via an unspecified route of administration administered in the right arm on 01May2021 12:30 as 1st dose, single for covid-19 immunization. Medical history included penicillin allergy. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccination. The patient was not diagnosed with covid-19 prior to the vaccination. The patient experienced extreme needle like pain across back and neck - the pain still continues, weakness in left arm, and initial faintness at onset. Due to these, the patient then went to the emergency room and all tests were "neg" on 03May2021. The patient was released with script for pain and muscle relaxer, but no treatment was received for the adverse events. The adverse events occurred on 03May2021 01:00, reported as approximately 36 hours after receiving the vaccine. The patient had not recovered from the adverse events at the time of the report. The patient has not been tested for covid-19 since the vaccination.
Woke up with arm sore, warm to the touch, and red with some swelling.
After receiving the 2nd vaccine, I had no pain or redness until about 12 days later when I broke out in hives from head to toe with severe itching. I had a rash everywhere that continued to spread within 24 hours. That resulted in 2 urgent care visits, and I had to take time off from work. The hives started going down my throat and appearing in my mouth. The medications worked rapidly, and the hives were gone after 18 hours of using the prednisone medication, creams, and allergy medication that was prescribed to me. There are still two marks that are swollen from where the hives originated in my mouth, but the hives are gone. They just possibly caused damage to the tissue. 2 days after that skin cancer started appearing on my body. They came very fast with squamous cancer cells. I had giant quarter size skin cancer that was on my leg that had to be surgically removed in about August 2021. I have new skin cancer appearing on my legs and hand now. I had two rounds of antibiotics. One was given before my biopsy and then the other one was given after the surgery.
Patient developed red, itchy lump at site of injection the day following injection. Said it has not gotten worse but it is not better either. Instructed him to use ice and try BENADRYL and to contact dr.
6 month to 4 year multidose, not mixed with required diluent. Bacteriostatic 0.9% Sodium Chloride used, by mistake.
administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) in an 84-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant and treatment medication was not reported. Number of doses administered was 102 doses. The vial did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Non significant follow up received on 08-Jun-2022.
pain at injection right arm; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-May-2021 and was forwarded to Moderna on 24-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at injection right arm) and FATIGUE (fatigue) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014MZ01 and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at injection right arm) and FATIGUE (fatigue). On 18-Mar-2021, VACCINATION SITE PAIN (pain at injection right arm) and FATIGUE (fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported  No treatment medication was reported
Left thigh swelling, warmth, pain and reluctance to walk developed in the afternoon after the vaccinations. Fussiness and low grade fever (100.4 farenheit) on 1/25/18.
Fever (highest at 101.8); Chills; Moderate nausea; Fatigue; Muscle aches in injection arm; This is a spontaneous report from a contactable nurse (patient). A 28-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL3248), intramuscular in left arm, on 09Jan2021 at 17:30, at a single dose, for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medication included ethinylestradiol/ ferrous fumarate/ norethisterone acetate (JUNEL FE). The patient previously took the first dose of BNT162B2 (Lot Number: EL0140) on 19Dec2020 (04:30 PM) for COVID-19 immunization (intramuscular in left arm). The patient had no known allergies. The patient was not diagnosed with COVID-19 prior to vaccination. No other vaccine was administered in four weeks. The most recent vaccine was administered in a hospital facility. On 10Jan2021 at 05:30 AM (day 1 post-dose number 2), the patient experienced fever (highest at 101.8) twice, chills, moderate nausea, fatigue, and muscle aches in injection arm. No treatment was administered for the events. Post-vaccination, the patient has not been tested for COVID-19. The patient recovered from the events in Jan2021.
I received my 5th Moderna Bivalent Booster on 10/12/2022. My symptoms started on 01/04/2023 in the morning at 08:00AM. I had a cough, no temperature, fatigue, and severe body aches. On 01/05/2022 I did home COVID-19 test which was negative. Since my husband tested positive for COVID-19 and I had symptoms of COVID-19 I contacted my doctor right away. Throughout the whole week I tested negative for COVID-19 infection. I called my doctor on  01/05/2023 who prescribe me with PAXLOVID. After few days my symptoms were getting worse so I called my doctor again on 01/10/2023 he prescribed me with doxycycline for 8 days and steroids.
found report of spontaneous urticaria; This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (found report of spontaneous urticaria) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (found report of spontaneous urticaria). At the time of the report, URTICARIA (found report of spontaneous urticaria) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
In January, have severe teeth pain. I had fever. Swollen lymph under left arm pit. Breast Biopsy.
several hrs p/vax pt began screaming unconsolably; screamed for approx 5-6 hrs straight; scream was very high pitched & abn;
Information has been received from a registered nurse concerning a 21-year-old female who on 05/24/2002 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #641459/0057M). On 05/24/2002, the same night of the vaccination, the pt experienced a high temperature and was achy and sweating. It was noted that the symptoms lasted all weekend. On 06/01/2002 the pt experienced eye pain if she looked right, left, up or down. Unspecified medical attention was sought. Follow-up info reported on 07/16/2002 stated that there was an "inability to gain mumps immunity and to date have had no response." Additional info has been requested.
Patient received 3 vaccines at 1219, reported to Clinic front desk feeling unwell. Vomited in clinic. Hives were noted at 1259. Patient received 2 doses of epi auto injector, 50mg of Benadryl and was transported to local emergency room at 1322.
nausea, dizziness, fatigue, headache Narrative:  Took Tylenol. Had COVID 11/24/20 and recovered
arm is extremely sore; arm is red; arm is hot; has been feeling nauseated; feel a knot under the skin; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm is extremely sore), VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE WARMTH (arm is hot), NAUSEA (has been feeling nauseated) and VACCINATION SITE INDURATION (feel a knot under the skin) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm is extremely sore), VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE WARMTH (arm is hot), NAUSEA (has been feeling nauseated) and VACCINATION SITE INDURATION (feel a knot under the skin). At the time of the report, PAIN IN EXTREMITY (arm is extremely sore), VACCINATION SITE ERYTHEMA (arm is red), VACCINATION SITE WARMTH (arm is hot), NAUSEA (has been feeling nauseated) and VACCINATION SITE INDURATION (feel a knot under the skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Information was received from a certified medical assistant (CMA) refers to an 18-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-JUN-2015, the patient was vaccinated with a dose of GARDASIL (lot number K014191 and expiration date 10-MAY-2017) (dose and route4 not reported) which was improperly stored. No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a health professional and refers to unspecified number of patients of unknown age and gender. The patient's medical histories, concurrent conditions, drug reactions and allergies were not reported. On an unknown date, the patient were probably vaccinated with doses of improperly stored ROTATEQ (dose, anatomical location, lot# and exp. date were not reported; route of administration defaulted to oral). Concomitant therapies were not reported. No adverse effects were reported. This is one of the two reports received from the same source. Additional information has been requested.
experiencing a flash before his eyes, a clear film formed in front of his eyes; This spontaneous case was reported by a consumer and describes the occurrence of EYE DISORDER (experiencing a flash before his eyes, a clear film formed in front of his eyes) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029H21B, 002A21A and 047A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EYE DISORDER (experiencing a flash before his eyes, a clear film formed in front of his eyes). At the time of the report, EYE DISORDER (experiencing a flash before his eyes, a clear film formed in front of his eyes) had resolved.            No concomitant medications were reported. No treatment medications were reported.    This case was linked to MOD-2021-057671 (Patient Link).
A non-serious spontaneous report of tenderness in nasal passage has been received from a registered nurse/health professional concerning a 35-year-old female, subsequent to H1N1, Intranasal. Neither relevant medical history nor concomitant medications were reported. In Nov-2009, about two weeks prior to reporting the adverse event, the patient received H1N1, Intranasal for an unknown indication. After vaccination, the patient began to experience tenderness in her nasal passage. The patient had described that her nasal passage was raw. The outcome of the reported events was not resolved.
potential side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of ADVERSE EVENT (potential side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ADVERSE EVENT (potential side effect). At the time of the report, ADVERSE EVENT (potential side effect) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
low grade fever....throughout the 1st night...next day fever, chills, and sweats throughout the night 2nd night
Dizziness (within 10 minutes of FLU vaccine admin.).  Fainted (between 10-15 minutes of administration).  Paramedics said that the patient had an episode of seizure.  Pt had a history of seizure (last time: 10 years ago).
This spontaneous report as received from a nurse and a health care worker refers to a 12 month old patient of unknown gender. On 11-APR-2013, the patient who was supposed to get PREVENAR 13 was inadvertently vaccinated with a dose of PNEUMOVAX23, 0.5 milliliter (ml), intramuscularly. No adverse effect reported. Reason why it occurred was unknown. Additional information has been requested.
Fainted for 5-10 seconds approximately 3-4 mintues after shot was given. Cool and clammy for 2-3 minutes.
Vaccine was given to patient yesterday. Today patient has redness on his left arm, very sore and very hot.
Information has been received from a consumer concerning her 15 year old son with a history of seizure who on 27-OCT-2011 was vaccinated with first dose of GARDASIL. On 03-FEB-2012 patient was vaccinated with second dose (lot #, route and site were not reported for both doses). There was no concomitant medication. At an unspecified time period after his first dose, her son started to experience tingling in his legs and "moody behavior". Her son was administered his second dose on 03-FEB-2012 and at an unspecified time period experienced tingling in his legs and his short term memory was "bad". Her son also experienced "blackouts". On 14-FEB-2012 her son's teacher sent a letter home to say that he was not grasping concepts at school. Her son had been out of school since 14-FEB-2012. Her son was referred by his primary care Physician. The mother called to office and her son was seen by neurologist. No treatment was given for the adverse event. Two Electroencephalo-graphs (EEG) were performed in which the results were pending. Her son would not be receiving his third dose. At the time of this report, the patient had not recovered from above events. Action taken with GARDASIL was discontinued. Short-term memory impairment, moody behavior, not grasping concepts in school, Loss of consciousness and tingling in his legs which made patient out of school for half a month were considered to be disabling. Additional information has been requested.
The day after vaccine thigh pain, 5 days after vaccine, thighs start have Shingles Visit doctor on 3/22/21, doctor prescribes medicine ? Zovirax?
Symptoms included extreme fatigue/ malaise that started a few hours after the vaccination; fever of 101 and rash to upper torso started 10/14/2009.
my symptoms were chills, fever, muscle pain, my skin hurt, fatigue, only treatment was tylenol and I went to bed